Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators
- PMID: 10805823
- DOI: 10.1056/NEJM200005113421902
Effects of physiologic pacing versus ventricular pacing on the risk of stroke and death due to cardiovascular causes. Canadian Trial of Physiologic Pacing Investigators
Abstract
Background: Evidence suggests that physiologic pacing (dual-chamber or atrial) may be superior to single-chamber (ventricular) pacing because it is associated with lower risks of atrial fibrillation, stroke, and death. These benefits have not been evaluated in a large, randomized, controlled trial.
Methods: At 32 Canadian centers, patients without chronic atrial fibrillation who were scheduled for a first implantation of a pacemaker to treat symptomatic bradycardia were eligible for enrollment. We randomly assigned patients to receive either a ventricular pacemaker or a physiologic pacemaker and followed them for an average of three years. The primary outcome was stroke or death due to cardiovascular causes. Secondary outcomes were death from any cause, atrial fibrillation, and hospitalization for heart failure.
Results: A total of 1474 patients were randomly assigned to receive a ventricular pacemaker and 1094 to receive a physiologic pacemaker. The annual rate of stroke or death due to cardiovascular causes was 5.5 percent with ventricular pacing, as compared with 4.9 percent with physiologic pacing (reduction in relative risk, 9.4 percent; 95 percent confidence interval, -10.5 to 25.7 percent [the negative value indicates an increase in risk]; P=0.33). The annual rate of atrial fibrillation was significantly lower among the patients in the physiologic-pacing group (5.3 percent) than among those in the ventricular-pacing group (6.6 percent), for a reduction in relative risk of 18.0 percent (95 percent confidence interval, 0.3 to 32.6 percent; P=0.05). The effect on the rate of atrial fibrillation was not apparent until two years after implantation. The observed annual rates of death from all causes and of hospitalization for heart failure were lower among the patients with a physiologic pacemaker than among those with a ventricular pacemaker, but not significantly so (annual rates of death, 6.6 percent with ventricular pacing and 6.3 percent with physiologic pacing; annual rates of hospitalization for heart failure, 3.5 percent and 3.1 percent, respectively). There were significantly more perioperative complications with physiologic pacing than with ventricular pacing (9.0 percent vs. 3.8 percent, P<0.001).
Conclusions: Physiologic pacing provides little benefit over ventricular pacing for the prevention of stroke or death due to cardiovascular causes.
Comment in
- ACP J Club. 2000 Nov-Dec;133(3):89
-
Effects of physiologic pacing versus ventricular pacing.N Engl J Med. 2000 Nov 9;343(19):1417-8; discussion 1418. N Engl J Med. 2000. PMID: 11183885 No abstract available.
-
Effects of physiologic pacing versus ventricular pacing.N Engl J Med. 2000 Nov 9;343(19):1418. N Engl J Med. 2000. PMID: 11183886 No abstract available.
Similar articles
-
Single-chamber versus dual-chamber pacing for high-grade atrioventricular block.N Engl J Med. 2005 Jul 14;353(2):145-55. doi: 10.1056/NEJMoa042283. N Engl J Med. 2005. PMID: 16014884 Clinical Trial.
-
Ventricular pacing or dual-chamber pacing for sinus-node dysfunction.N Engl J Med. 2002 Jun 13;346(24):1854-62. doi: 10.1056/NEJMoa013040. N Engl J Med. 2002. PMID: 12063369 Clinical Trial.
-
Quality of life and clinical outcomes in elderly patients treated with ventricular pacing as compared with dual-chamber pacing. Pacemaker Selection in the Elderly Investigators.N Engl J Med. 1998 Apr 16;338(16):1097-104. doi: 10.1056/NEJM199804163381602. N Engl J Med. 1998. PMID: 9545357 Clinical Trial.
-
Role of permanent pacing to prevent atrial fibrillation: science advisory from the American Heart Association Council on Clinical Cardiology (Subcommittee on Electrocardiography and Arrhythmias) and the Quality of Care and Outcomes Research Interdisciplinary Working Group, in collaboration with the Heart Rhythm Society.Circulation. 2005 Jan 18;111(2):240-3. doi: 10.1161/01.CIR.0000151800.84945.47. Circulation. 2005. PMID: 15657388 Review.
-
Evolutionary innovations in cardiac pacing.J Electrocardiol. 2011 Nov-Dec;44(6):611-5. doi: 10.1016/j.jelectrocard.2011.07.021. Epub 2011 Sep 13. J Electrocardiol. 2011. PMID: 21920533 Review.
Cited by
-
Report of the NASPE/NHLBI Round Table on Future Research Directions in Atrial Fibrillation. North American Society of Pacing and Electrophysiology.J Interv Card Electrophysiol. 2001 Sep;5(3):345-64. doi: 10.1023/a:1011489306778. J Interv Card Electrophysiol. 2001. PMID: 11500592 Review. No abstract available.
-
Sinus node dysfunction: current understanding and future directions.Am J Physiol Heart Circ Physiol. 2023 Mar 1;324(3):H259-H278. doi: 10.1152/ajpheart.00618.2022. Epub 2022 Dec 23. Am J Physiol Heart Circ Physiol. 2023. PMID: 36563014 Free PMC article. Review.
-
Dual site right atrial pacing can improve the impact of standard dual chamber pacing on atrial and ventricular mechanical function in patients with symptomatic atrial fibrillation: further observations from the dual site atrial pacing for prevention of atrial fibrillation trial.J Interv Card Electrophysiol. 2005 Apr;12(3):177-87. doi: 10.1007/s10840-005-1346-2. J Interv Card Electrophysiol. 2005. PMID: 15875108 Clinical Trial.
-
Magnetic resonance imaging, pacemakers and implantable cardioverter-defibrillators: current situation and clinical perspective.Neth Heart J. 2010 Jan;18(1):31-7. Neth Heart J. 2010. PMID: 20111641 Free PMC article.
-
[Fitness to drive in patients with cardiovascular implantable electronic devices].Herzschrittmacherther Elektrophysiol. 2019 Jun;30(2):150-155. doi: 10.1007/s00399-019-0626-y. Epub 2019 May 9. Herzschrittmacherther Elektrophysiol. 2019. PMID: 31073643 Review. German.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical